Previously treated cases tested for RR-/MDR-TB in Czechia
Czechia: Previously treated cases tested for RR-/MDR-TB was 58.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Czechia, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Czechia stood at 58.0%.
Compared with earlier readings it is down 19.4% on the previous year and up 28.9% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Czechia peaked at 83.0% in 2020 and was at its lowest, 33.0%, in 2013.
That places Czechia 140th out of 180 countries with data for 2024, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Czechia, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 59.0% | — |
| 2006 | 47.0% | -20.3% |
| 2007 | 56.0% | +19.1% |
| 2008 | 61.0% | +8.9% |
| 2009 | 63.0% | +3.3% |
| 2010 | 61.0% | -3.2% |
| 2011 | 53.0% | -13.1% |
| 2012 | 65.0% | +22.6% |
| 2013 | 33.0% | -49.2% |
| 2014 | 45.0% | +36.4% |
| 2015 | 64.0% | +42.2% |
| 2016 | 54.0% | -15.6% |
| 2017 | 52.0% | -3.7% |
| 2018 | 71.0% | +36.5% |
| 2019 | 61.0% | -14.1% |
| 2020 | 83.0% | +36.1% |
| 2021 | 75.0% | -9.6% |
| 2022 | 71.0% | -5.3% |
| 2023 | 72.0% | +1.4% |
| 2024 | 58.0% | -19.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 57.2% | 47.0% | 63.0% | 5 |
| 2010s | 55.9% | 33.0% | 71.0% | 10 |
| 2020s | 71.8% | 58.0% | 83.0% | 5 |
Countries ranked near Czechia
More health data for Czechia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.7726 % change on previous year (2090)
- Heat deaths vs projected death rates 1,169 (2090)
- Un projection of annual infant deaths 34 (2100)
- Population ages 65 and above, female, annual growth rate 1.3 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.122 units per person (2025)
- Population ages 65 and above, male, annual growth rate 1.62 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0898 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Czechia?
- Previously treated cases tested for rr-/mdr-tb in Czechia was 58.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Czechia?
- The highest recorded value was 83.0% in 2020.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Czechia?
- The lowest recorded value was 33.0% in 2013.
- How does Czechia rank for previously treated cases tested for rr-/mdr-tb?
- Czechia ranks 140th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Czechia?
- Over the last ten years it is up 28.9%. The long-run trend across the full record is rising.
- Where does this Czechia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).